We demonstrate that the formation of actin comets in OCRL deficiency can be alleviated by reducing PI(3)P levels using PI 3-kinase inhibitors, suggesting a possible therapeutic strategy in Lowe syndrome. This evidence concerns the gene OCRL and oculocerebrorenal syndrome.